In this note, we will discuss the latest decisions on the merits from the Dutch patent court on the matter of plausibility and inventive step.

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Lexington High School held its annual Veterans Day program on Monday afternoon, honoring veterans from various branches of ...

LVMH plans to ramp up manufacturing at its Zenith brand to supply movements for timepieces across the luxury group’s watch ...

Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...

The two-day event will see industry experts from across the clinical trial space holding talks on subjects from AI to ...

Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration ...

Swiss generic and biosimilar medicines major Sandoz today announced that the European Commission (EC) has granted marketing ...

Sandoz (SDZNY) announced that the European Commission, or EC, has granted marketing authorization for Afqlir 2 mg vial kit and pre-filled syringe ...

Afqlir is indicated to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) ...

Sandoz (SDZNY) said that the European Commission has granted marketing authorization for Afqlir (aflibercept) 2 mg vial kit and ...